gliclazide and Angiogenesis, Pathologic

gliclazide has been researched along with Angiogenesis, Pathologic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bosland, MC; Chen, A; Dakshinamoorthy, G; Gnanasekar, M; Kajdacsy-Balla, A; Samykutty, A; Shetty, AV; Thirugnanam, S; Zheng, G	1

Other Studies

1 other study(ies) available for gliclazide and Angiogenesis, Pathologic

Article	Year
18α-glycyrrhetinic acid targets prostate cancer cells by down-regulating inflammation-related genes. International journal of oncology, 2011, Volume: 39, Issue:3 Topics: Animals; Antineoplastic Agents; Cattle; Cell Growth Processes; Cell Line, Tumor; Down-Regulation; Endothelial Cells; Gene Expression Regulation, Neoplastic; Glycyrrhetinic Acid; Humans; Inflammation; Male; Matrix Metalloproteinase 9; Neovascularization, Pathologic; Prostatic Neoplasms; Transcription Factor RelA; Vascular Endothelial Growth Factor A	2011

Article

Year

18α-glycyrrhetinic acid targets prostate cancer cells by down-regulating inflammation-related genes.

International journal of oncology, 2011, Volume: 39, Issue:3

Topics: Animals; Antineoplastic Agents; Cattle; Cell Growth Processes; Cell Line, Tumor; Down-Regulation; Endothelial Cells; Gene Expression Regulation, Neoplastic; Glycyrrhetinic Acid; Humans; Inflammation; Male; Matrix Metalloproteinase 9; Neovascularization, Pathologic; Prostatic Neoplasms; Transcription Factor RelA; Vascular Endothelial Growth Factor A

2011